Sakar Healthcare Limited has informed the Exchange about General Updates
SAKAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
At the 21st Annual General Meeting held on 23rd September 2025, shareholders of Sakar Healthcare approved the appointment of three Non-Executive Independent Directors — Ms. Megha Samdani, Ms. Reeya Kothari, and Ms. Hiral Patel — each for a 5-year term effective 25th July 2025. All three are qualified Company Secretaries with backgrounds spanning corporate law, finance, taxation, and secretarial compliance. None of them hold shares in the company and none are related to existing directors. Additionally, M/s. Nishant Pandya & Associates, Practising Company Secretaries, was appointed as the Secretarial Auditor for a 5-year term covering FY 2025-26 to FY 2029-30.
This is a routine corporate governance update reflecting board strengthening with three new independent directors and a new secretarial auditor. No immediate material impact on stock price is expected, though it demonstrates compliance with listing regulations and board refreshment.